8-K: Hinge Health Reports Strong Q1 2026 Results, Raises Full-Year Outlook

Hinge Health announced record first quarter 2026 financial results with 47% year-over-year revenue growth and raised its full-year revenue outlook.

Summary

• Hinge Health reported first quarter 2026 revenue of $182.3 million, a 47% increase year-over-year from $123.8 million in Q1 2025.
• GAAP gross margin improved to 85% from 81% in the prior year's quarter.
• GAAP income from operations surged 144% to $32.1 million, and non-GAAP income from operations increased 208% to $46.2 million.
• Net cash provided by operating activities was $43.1 million, a significant increase from $4.9 million in Q1 2025.
• Free cash flow also saw a substantial rise to $41.6 million from $4.2 million in the same period last year.
• The company raised its full-year 2026 revenue outlook to between $798 million and $804 million, with an expected non-GAAP operating margin of 26%.
• Hinge Health also announced the launch of its Migraine Care Program.

Sentiment

Score: 9

Explanation: StockSavvy.ai views this as a very positive filing, with strong financial performance, raised guidance, and strategic program expansion indicating robust business momentum and execution.

Positives

• Revenue growth of 47% year-over-year to $182.3 million in Q1 2026.
• GAAP gross margin improved to 85% from 81% in Q1 2025.
• GAAP income from operations increased by 144% to $32.1 million.
• Non-GAAP income from operations increased by 208% to $46.2 million.
• Net cash provided by operating activities increased to $43.1 million from $4.9 million.
• Free cash flow increased to $41.6 million from $4.2 million.
• Full-year revenue outlook raised by approximately $64 million at the midpoint to $801 million.
• Non-GAAP operating margin for the full year is expected to be 26%.

Negatives

• While not explicitly negative, the company notes that non-GAAP financial measures have limitations and may not be comparable to similar measures of other companies.
• The company is unable to provide GAAP income from operations guidance due to the uncertainty of reconciling items like stock-based compensation and acquisition-related expenses.

Risks

• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, as detailed in filings with the SEC.
• The company's reliance on non-GAAP financial measures means that GAAP results could differ significantly due to excluded items.

Future Outlook

For the second quarter of 2026, Hinge Health expects revenue between $194 million and $196 million, with non-GAAP income from operations between $47 million and $49 million. For the full year 2026, revenue is projected to be between $798 million and $804 million, with non-GAAP income from operations between $205 million and $215 million, and a non-GAAP operating margin of 26%.

Management Comments

• "We generated $182 million in revenue this quarter with 47% year-over-year growth, well ahead of expectations, driven by the strength of a platform that automates care delivery, improves member outcomes and lowers costs," said Daniel Perez, Co-Founder and CEO, Hinge Health.
• "Based on this momentum, we're raising our full-year revenue outlook by approximately $64 million at the midpoint to $801 million, while expanding non-GAAP operating margin to 26%."
• "We also recently announced our Migraine Care Program, an important step in expanding our platform. We didn't build this company to stop at digital physical therapy; we built it to transform how healthcare is delivered at scale."

Industry Context

StockSavvy.ai notes that Hinge Health's strong performance and raised outlook align with the growing trend of digital health solutions aimed at improving patient outcomes and reducing healthcare costs. The expansion into new care programs like Migraine Care indicates a strategic move to broaden its platform's reach and address a wider range of chronic conditions, a common growth strategy in the competitive digital health market.

Comparison to Industry Standards

• Hinge Health's reported 47% year-over-year revenue growth in Q1 2026 significantly outpaces the average growth rates seen in the broader digital health sector, which has experienced more moderate growth in recent periods.
• The company's non-GAAP operating margin of 25% for Q1 2026 and projected 26% for the full year are strong indicators of operational efficiency, potentially exceeding industry benchmarks for companies at a similar stage of growth and scale.
• The substantial increase in free cash flow to $41.6 million demonstrates robust financial health, a key metric that many digital health companies are striving to achieve as they mature.

Stakeholder Impact

• Shareholders: Positive impact due to strong financial performance, raised outlook, and potential for increased shareholder value.
• Employees: Continued growth and expansion may lead to job creation and opportunities within the company.
• Customers (Clients): Benefit from improved member outcomes, automated care delivery, and cost reductions.
• Suppliers/Creditors: Increased revenue and cash flow suggest a stable and reliable business partner.

Next Steps

• Hold conference call and webcast on May 5, 2026, to discuss financial results.
• Continue to scale and automate healthcare delivery through its AI-powered care model.
• Expand its platform with new care programs.

Key Dates

Recommendation

The company demonstrated exceptional Q1 2026 performance, significantly exceeding prior expectations with strong revenue growth and improved profitability metrics. The raised full-year guidance, coupled with strategic expansion into new care areas, indicates sustained momentum and a positive trajectory. This combination of strong execution and optimistic future outlook warrants a strong buy recommendation for investors.

Keywords

Hinge Health, Q1 2026 Earnings, Revenue Growth, Digital Health, Healthcare Automation, Financial Results, Operating Margin, Migraine Care